BioNTech SE (BNTX) Stock Statistics & Valuation Metrics

BioNTech SE has a market cap or net worth of $26.45B. The enterprise value is $12.71B.

BioNTech SE has 246,236,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

BioNTech SE’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -6.44%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, BioNTech SE had revenue of 2.75B and earned -665.30M in profits. Earnings per share was -2.77.

In the last 12 months, operating cash flow was -219.29M and capital expenditures -932.66M, giving a free cash flow of -1.15B billion.

BioNTech SE pays an annual dividend of $2.111, resulting in a dividend yield of ―

BioNTech SE upcoming earnings date is Aug 4, 2025, Before Open (Confirmed).

BioNTech SE as a current ratio of 7.45, with Debt / Equity ratio of 1.55%

In the past 12 months, BioNTech SE has paid -12.40M in taxes.

BioNTech SE EV to EBITDA ratio is -46.16, with an EV/FCF ratio of -69.28.

BioNTech SE has $14.11B in cash and marketable securities with €293.00M in debt, giving a net cash position of -$13.82B billion.

Gross margin is 79.35%, with operating margin of -47.77%, and net profit margin of -24.18%.

The average price target for BioNTech SE is $138.59, which is 11.43% higher than the current price. The consensus rating is Moderate Buy